Why Staying on Your IBD Medication Matters

In this episode of Sage Infusion Deep Dive, we focus on digestive health in recognition of National Colon Cancer Awareness Month and explore a critical message for patients living with Crohn’s disease and ulcerative colitis: controlling inflammation today protects your future health.Chronic inflammation from IBD doesn’t just cause uncomfortable symptoms — over time, it can increase the risk of serious complications, including colon cancer. We break down how advanced biologic therapies like Remicade, Entyvio, Skyrizi, Tremfya, and Stelara help calm the immune system, promote healing of the bowel lining, and reduce long-term cancer risk.We also discuss why staying on schedule with your infusions matters, the dangers of skipping doses, and how infusion therapy combined with routine colonoscopy surveillance creates a powerful prevention strategy.If you’re receiving IBD treatment — or supporting someone who is — this episode explains why feeling better isn’t the finish line. True disease control means protecting your colon for the long haul.This podcast is generated using artificial intelligence. The information provided is for informational purposes only and should not be construed as legal, medical, or professional advice. We encourage listeners to seek appropriate medical advice for specific healthcare concerns as it relates to their condition or treatment. The information provided is general and may not apply to individual circumstances. Do not attempt to solve individual medical problems based on the information provided in this podcast.Sage Infusion content used to generate podcast:https://sageinfusion.com/2026/02/24/why-staying-on-your-ibd-medication-matters/ https://sageinfusion.com/2026/03/01/controlling-inflammation-to-reduce-colon-cancer-risk-in-ibd/